Pricing Log in Create free account
Saturday 17 October 2026 Export EW’s income statement to Excel — free account

Edwards Lifesciences Corporation

EW Healthcare Medical Devices

Edwards Lifesciences Corporation’s revenue for fiscal 2025 (year ended December 2025) was $6.1 billion, up 11.5% from fiscal 2024. In the quarter to June 2026, revenue grew 13.6%, EPS fell 26.3%, free cash flow grew 142.8% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.

86.60 1.50 −1.70%
Market cap
$50.8B
P/E
49.8×
Fwd P/E
30.7×
Dividend yield
—
F-score
5/9
Altman Z
11.54
Beneish M
−2.48
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Edwards Lifesciences Corporation (EW) EPS (diluted)

Alert me on EPS (diluted)

Edwards Lifesciences Corporation's EPS (diluted) for fiscal 2025 was $1.83, down 73.7% from $6.97 in fiscal 2024. Over the twelve months to 30 June 2026 it was $1.74. Over the past ten years it has ranged from $0.75 (fiscal 2015) to $6.97 (fiscal 2024); the current reading is higher than 64% of that period. Edwards Lifesciences Corporation ranks 27th of 147 Medical Devices companies by EPS (diluted).

EPS (diluted), annual

Embed this chart

Annual newest first

Period EPS (diluted) Change
FY2025 $1.83 (73.74%)
FY2024 $6.97 203.04%
FY2023 $2.30 (5.74%)
FY2022 $2.44 2.52%
FY2021 $2.38 83.08%
FY2020 $1.30 (20.89%)
FY2019 $1.64 45.85%
FY2018 $1.13 17.36%
FY2017 $0.96 10.34%
FY2016 $0.87 16.00%

Quarterly newest first

Period EPS (diluted) Change
Jun 2026 $0.42 (36.36%)
Mar 2026 $0.66 312.50%
Dec 2025 $0.16 (68.00%)
Sep 2025 $0.50 (10.71%)
42 more quarters

Against its own ten years

Low $0.75 High $6.97
Ten-year median $1.64
Current reading's percentile 64

EPS (diluted) against peers

Company EPS (diluted)
SYK Stryker Corporation compare $9.65
STE STERIS plc compare $8.18
GEHC GE HealthCare Technologies Inc. compare $4.36
ZBH Zimmer Biomet Holdings, Inc. compare $4.11
MDT Medtronic PLC compare $4.06
DXCM DexCom, Inc. compare $2.53
BSX Boston Scientific Corporation compare $2.47
EW Edwards Lifesciences Corporation $1.74
PHG Koninklijke Philips N.V. compare $1.36

What EPS (diluted) is

Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.

Reported line item

The full definition of EPS (diluted) →

More on EW